House Panel Will Target FDA Device Efforts, Health Reform
This article was originally published in The Gray Sheet
Executive Summary
The House Energy and Commerce Committee plans to scrutinize FDA’s device approvals closely over the next two years, to be certain that extensive regulatory processes do not force industry jobs overseas, nor interfere with innovation, according to a committee oversight plan agreed to Feb. 15.
You may also be interested in...
House Committees Set Key Subpanel Assignments For 113th Congress
Two House committees important to the device industry – Ways & Means and Energy & Commerce – have organized for the 2013-2014 sessions.
Shuren On The Hill: Industry Should Take More Blame For Review Delays
CDRH Director Jeffrey Shuren called out industry during a Feb. 17 House subcommittee hearing for playing a significant role in causing delays in pre-market device reviews.
Capitol Hill In Brief
More comparative effectiveness clashes